Home/Invenio Imaging/Chris Freudiger, PhD
CF

Chris Freudiger, PhD

Chief Technology Officer & Co-Founder

Invenio Imaging

Therapeutic Areas

Invenio Imaging Pipeline

DrugIndicationPhase
NIO Laser Imaging SystemIntraoperative tissue evaluation across multiple cancersCommercial
NIO Glioma RevealDiffuse Glioma (Brain Cancer)CE Mark (EU); Research Use Only (US)
AI for Lung CancerLung CancerResearch
AI for Prostate CancerProstate CancerResearch